Kemnay Advisory Services Inc. Sarepta Therapeutics, Inc. Transaction History

Kemnay Advisory Services Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $410,452 - $959,804	-5,681 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $713,306 - $1.02 Million	5,681 New	5,681 $969,000
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $463,860 - $628,868	-3,649 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $435,612 - $804,242	-4,684 Reduced 56.21%	3,649 $585,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $1.04 Million - $1.66 Million	-12,576 Reduced 60.15%	8,333 $815,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $1.6 Million - $2.83 Million	20,909 New	20,909 $2.7 Million

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Kemnay Advisory Services Inc., based on Form 13F filings with the SEC.

Stay updated on Kemnay Advisory Services Inc. with notifications on news.